| abstract |
The present invention relates to the treatment of iron overload diseases and/or, including, in particular, certain hepcidin peptide analogs, including peptides and dimers thereof, and congenital hemochromatosis and iron-load anemia, and other conditions and disorders described herein. It relates to the use of such peptides and peptide dimers in the treatment and/or prophylaxis of various diseases, conditions or disorders, including prophylaxis. |